Galera Therapeutics, Inc.
GRTXDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563577
Galera Therapeutics, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Aug 5, 2026; 36 institutions reported holding it in 13F filings for Q1 2024, worth $1.37M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Galera Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 47 | 40 | −7 |
| Shares | 20.5M | 20.0M | −528.1K (−2.6%) |
| Value | $201.5M | $161.8M | −$39.7M (−19.7%) |
New holders (1)
Institutions that held Galera Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Migdal Insurance & Financial Holdings Ltd. | 1,322 | $11.0K | 0.00% |
Sold out (8)
Institutions that held Galera Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Perceptive Advisors LLC | 254,664 | $2.50M |
| Tibra Equities Europe Ltd | 36,900 | $363.0K |
| ExodusPoint Capital Management, LP | 25,179 | $248.0K |
| Jump Financial, LLC | 18,000 | $177.0K |
| Signaturefd, LLC | 1,000 | $10.0K |
| Panagora Asset Management Inc | 566 | $6.00K |
| UBS Group AG | 284 | $3.00K |
| New York State Common Retirement Fund | 75 | $1.00K |